PT
Palvella Therapeutics, Inc
🇺🇸XNAS.PVLAUnited StatesHealthcare
$153.52USDup +2.03 (+1.34%)OpenDelayed6:03 PM
Price$153.52+2.03 (+1.34%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US6979471090
- CUSIP
- Not reported
Company
- Employees
- 29
- Headquarters
- Wayne, United States
- Website
- https://palvellatx.com
- CEO
- Mr. Wesley H. Kaupinen
Market
- Shares outstanding
- 14.4M
- Market cap
- $2.21B
Highlights
- Market cap
- $2.18B
- EPS LTM
- -$4.30
- P/E LTM
- -34.83
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$61.7M-117.38%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$36.51M-79.54%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.